Human cellular differences in cAMP--CREB signaling correlate with light-dependent melatonin suppression and bipolar disorder.

Ludmila Gaspar
Ludmila Gaspar
University of Zurich
Anne-Sophie Johansson
Anne-Sophie Johansson
University of Zurich
Ermanno Moriggi
Ermanno Moriggi
Institute of Pharmacology and Toxicology
Bjorn Owe-Larsson
Bjorn Owe-Larsson
Skubiszewski Medical University
Gabriella B Lundkvist
Gabriella B Lundkvist
Karolinska Institutet

Eur J Neurosci 2014 Jul 5;40(1):2206-15. Epub 2014 Jun 5.

Institute of Pharmacology and Toxicology, University of Zurich, 190 Winterthurerstrasse, Zurich, Switzerland.

Various lines of evidence suggest a mechanistic role for altered cAMP-CREB (cAMP response element - binding protein) signaling in depressive and affective disorders. However, the establishment and validation of human inter-individual differences in this and other major signaling pathways has proven difficult. Here, we describe a novel lentiviral methodology to investigate signaling variation over long periods of time directly in human primary fibroblasts. On a cellular level, this method showed surprisingly large inter-individual differences in three major signaling pathways in human subjects that nevertheless correlated with cellular measures of genome-wide transcription and drug toxicity. We next validated this method by establishing a likely role for cAMP-mediated signaling in a human neuroendocrine response to light - the light-dependent suppression of the circadian hormone melatonin - that shows wide inter-individual differences of unknown origin in vivo. Finally, we show an overall greater magnitude of cellular CREB signaling in individuals with bipolar disorder, suggesting a possible role for this signaling pathway in susceptibility to mental disease. Overall, our results suggest that genetic differences in major signaling pathways can be reliably detected with sensitive viral-based reporter profiling, and that these differences can be conserved across tissues and be predictive of physiology and disease susceptibility.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
July 2014
18 Reads

Publication Analysis

Top Keywords

inter-individual differences
signaling pathways
major signaling
bipolar disorder
differences major
toxicity validated
drug toxicity
transcription drug
validated method
genome-wide transcription
method establishing
neuroendocrine response
response light
light light-dependent
human neuroendocrine
signaling human
establishing role


(Supplied by CrossRef)
Antidepressant chronotherapeutics for bipolar depression
Benedetti et al.
Dialogues Clin. Neurosci. 2012
Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response
Blier et al.
J. Psychiatr. Neurosci. 2001
Molecular insights into human daily behavior
Brown et al.
Proc. Natl. Acad. Sci. USA 2008

Similar Publications

Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation.

BMB Rep 2018 Oct 8. Epub 2018 Oct 8.

Laboratoire de Biologie et Modelisation de la Cellule, Universite de Lyon, CNRS UMR 5239, INSERM U1210, Ecole Normale Superieure de Lyon, Universite Claude Bernard Lyon 1, F-69007 Lyon, France.

RNA helicases DDX5 and DDX17 are multitasking proteins that regulate gene expression in different biological contexts through diverse activities. Special attention has long been paid to their function as coregulators of transcription factors, providing insight about their functional association with a number of chromatin modifiers and remodelers. However, to date, the variety of described mechanisms has made it difficult to understand precisely how these proteins work at the molecular level, and the contribution of their ATPase domain to these mechanisms remains unclear as well. Read More

View Article
October 2018
8 Reads
2.60 Impact Factor

A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Schizophr Res 2018 Jun 20. Epub 2018 Jun 20.

Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.

Aims: To provide quantitative conversions between commonly used scales for the assessment of negative symptoms in schizophrenia.

Method: Linear regression analyses generated conversion equations between symptom scores from the Scale for the Assessment of Negative Symptoms (SANS), the Schedule for the Deficit Syndrome (SDS), the Positive and Negative Syndrome Scale (PANSS), or the Negative Symptoms Assessment (NSA) based on a cross sectional sample of 176 individuals with schizophrenia. Intraclass correlations assessed the rating conversion accuracy based on a separate sub-sample of 29 patients who took part in the initial study as well as an independent sample of 28 additional subjects with schizophrenia. Read More

View Article
June 2018
9 Reads
3.92 Impact Factor

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

J Antimicrob Chemother 2017 10;72(10):2869-2878

Assistance Publique-Hôpiteaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France.

Background: CD4 cell recovery following first-line combination ART (cART) is poorer in HIV-2+ than in HIV-1+ patients. Only large comparisons may allow adjustments for demographic and pretreatment plasma viral load (pVL).

Methods: ART-naive HIV+ adults from two European multicohort collaborations, COHERE (HIV-1 alone) and ACHIeV2e (HIV-2 alone), were included, if they started first-line cART (without NNRTIs or fusion inhibitors) between 1997 and 2011. Read More

View Article
October 2017
39 Reads
1 PubMed Central Citation(source)
5.31 Impact Factor

Slovenia: Health System Review.

Health Syst Transit 2016 Jun;18(3):1-207

European Observatory on Health Systems and Policies.

This analysis of the Slovene health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. The health of the population has improved over the last few decades. While life expectancy for both men and women is similar to EU averages, morbidity and mortality data show persistent disparities between regions, and mortality from external causes is particularly high. Read More

View Article
June 2016
39 Reads
3 PubMed Central Citations(source)

Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005.

JAMA 2010 May;303(18):1841-7

Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Context: Coronary heart disease (CHD) mortality has declined substantially in Canada since 1994.

Objective: To determine what proportion of this decline was associated with temporal trends in CHD risk factors and advancements in medical treatments.

Design, Setting, And Patients: Prospective analytic study of the Ontario, Canada, population aged 25 to 84 years between 1994 and 2005, using an updated version of the validated IMPACT model, which integrates data on population size, CHD mortality, risk factors, and treatment uptake changes. Read More

View Article
May 2010
14 Reads
76 PubMed Central Citations(source)
35.29 Impact Factor